Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul 30;12(8):1013.
doi: 10.3390/brainsci12081013.

Biomarkers of Relapse in Cocaine Use Disorder: A Narrative Review

Affiliations
Review

Biomarkers of Relapse in Cocaine Use Disorder: A Narrative Review

Margaux Poireau et al. Brain Sci. .

Abstract

Introduction: Cocaine use disorder is a chronic disease with severe consequences and a high relapse rate. There is a critical need to explore the factors influencing relapse in order to achieve more efficient treatment outcomes. Furthermore, there is a great need for easy-to-measure, repeatable, and valid biomarkers that can predict treatment response or relapse.

Methods: We reviewed the available literature on the Pubmed database concerning the biomarkers associated with relapse in CUD, including central nervous system-derived, genetic, immune, oxidative stress, and "other" biomarkers.

Results: Fifty-one articles were included in our analysis. Twenty-five imaging brain anatomic and function assessment studies, mostly using fMRI, examined the role of several structures such as the striatum activity in abstinence prediction. There were fewer studies assessing the use of neuropsychological factors, neurotrophins, or genetic/genomic factors, immune system, or oxidative stress measures to predict abstinence.

Conclusion: Several biomarkers have been shown to have predictive value. Prospective studies using combined multimodal assessments are now warranted.

Keywords: biomarkers; cocaine use disorder; relapse; treatment response.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow-chart of the article selection process.

Similar articles

Cited by

References

    1. Pitchot W., Scantamburlo G., Pinto E., Karila L. Cocaine Addiction. Rev. Med. Liege. 2013;68:294–297. - PubMed
    1. Wouldes T.A., Lester B.M. Stimulants: How big is the problem and what are the effects of prenatal exposure? Semin. Fetal Neonatal Med. 2019;24:155–160. doi: 10.1016/j.siny.2019.01.011. - DOI - PubMed
    1. Clergue-Duval V., Nicolas-Sacy L., Karsinti E., Zerdazi E.-H., Laplanche J.-L., Brousse G., Marees A.T., Derks E.M., Henry P., Bellivier F., et al. Risk and Protective Factors of Lifetime Cocaine-Associated Chest Pain. Front. Psychiatry. 2021;12:704276. doi: 10.3389/fpsyt.2021.704276. - DOI - PMC - PubMed
    1. Chychula N.M., Okore C. The cocaine epidemic: A comprehensive review of use, abuse and dependence. Nurse Pract. 1990;15:31–39. doi: 10.1097/00006205-199008000-00008. - DOI - PubMed
    1. Vorspan F., Brousse G., Bloch V., Bellais L., Romo L., Guillem E., Coeuru P., Lépine J.-P. Cocaine-induced psychotic symptoms in French cocaine addicts. Psychiatry Res. 2012;200:1074–1076. doi: 10.1016/j.psychres.2012.04.008. - DOI - PubMed

LinkOut - more resources